{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:58:45Z","timestamp":1770962325076,"version":"3.50.1"},"reference-count":77,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2014,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Biofilms play a role in the pathogenicity of pneumococcal infections. A pharmacodynamic\n            <jats:italic>in vitro<\/jats:italic>\n            model of biofilm was developed that allows characterization of the activity of antibiotics against viability and biomass by using in parallel capsulated (ATCC 49619) and noncapsulated (R6) reference strains. Naive biofilms were obtained by incubating fresh planktonic cultures for 2 to 11 days in 96-well polystyrene plates. Induced biofilms were obtained using planktonic bacteria collected from the supernatant of 6-day-old naive biofilms. Biomass production was more rapid and intense in the induced model, but the levels were similar for both strains. Full concentration responses fitting sigmoidal regressions allowed calculation of maximal efficacies and relative potencies of drugs. All antibiotics tested (amoxicillin, clarithromycin, solithromycin, levofloxacin, and moxifloxacin) were more effective against young naive biofilms than against old or induced biofilms, except macrolides\/ketolides, which were as effective at reducing viability in 2-day-old naive biofilms and in 11-day-old induced biofilms of R6. Macrolides\/ketolides, however, were less potent than fluoroquinolones against R6 (approximately 5- to 20-fold-higher concentrations needed to reduction viability of 20%). However, at concentrations obtainable in epithelial lining fluid, the viabilities of mature or induced biofilms were reduced 15 to 45% (amoxicillin), 17 to 44% (macrolides\/ketolides), and 12 to 64% (fluoroquinolones), and biomasses were reduced 5 to 45% (amoxicillin), 5 to 60% (macrolides\/ketolides), and 10 to 76% (fluoroquinolones), with solithromycin and moxifloxacin being the most effective and the most potent agents (due to lower MICs) in their respective classes. This study allowed the ranking of antibiotics with respect to their potential effectiveness in biofilm-related infections, underlining the need to search for still more effective options.\n          <\/jats:p>","DOI":"10.1128\/aac.01858-13","type":"journal-article","created":{"date-parts":[[2013,12,17]],"date-time":"2013-12-17T02:23:13Z","timestamp":1387246993000},"page":"1348-1358","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":19,"title":["Antibiotic Activity against Naive and Induced Streptococcus pneumoniae Biofilms in an\n            <i>In Vitro<\/i>\n            Pharmacodynamic Model"],"prefix":"10.1128","volume":"58","author":[{"given":"Nathalie M.","family":"Vandevelde","sequence":"first","affiliation":[{"name":"Pharmacologie cellulaire et mol\u00e9culaire, Louvain Drug Research Institute, Universit\u00e9 catholique de Louvain, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul M.","family":"Tulkens","sequence":"additional","affiliation":[{"name":"Pharmacologie cellulaire et mol\u00e9culaire, Louvain Drug Research Institute, Universit\u00e9 catholique de Louvain, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Van Bambeke","sequence":"additional","affiliation":[{"name":"Pharmacologie cellulaire et mol\u00e9culaire, Louvain Drug Research Institute, Universit\u00e9 catholique de Louvain, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.15.2.167-193.2002"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.2436\/20.1501.01.84"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5418.1318"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1462-5822.2009.01323.x"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a000398"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.11.2517"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2006.05310.x"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.2174\/092986711795656216"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/0194599812438169"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.2.202"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1086\/597042"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlg.0000221954.05467.54"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl482"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00425-08"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-8-173"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2010.03.016"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2010.01.002"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00200-12"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019844"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.3342\/ceo.2012.5.3.139"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/039463201102400420"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2010.02587.x"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2007.06.029"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028738"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1086\/598483"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.12.076"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/imammb\/21.2.147"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro821"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-12-102"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.2012.01006.x"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01123-09"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00197-13"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.30.4.961-966.1992"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.79.2.137"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.183.19.5709-5717.2001"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.181.8.2652-2654.1999"},{"key":"e_1_3_3_38_2","volume-title":"22nd informational supplement (MS100-S22)","author":"Clinical and Laboratory Standards Institute","year":"2012","unstructured":"Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing. 22nd informational supplement (MS100-S22). Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.37.1.318-326.1982"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-765X.2007.02298.x"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.02095-09"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2672.2008.03823.x"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr572"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1116670109"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00673-06"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2010.02703.x"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-11-75"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00181-13"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.2000.01606.x"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.188.7.2325-2335.2006"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00488-12"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/aem.57.7.2079-2084.1991"},{"key":"e_1_3_3_53_2","first-page":"53","volume-title":"Advances in biofilm science and engineering","author":"Ceri H","year":"2004","unstructured":"CeriHOlsonMEMorckDW. 2004. Methods for biofilm study and assays for biofilm susceptibility and target recognition: approaches to deal with the biofilm mode of life, p 53\u201385. In JordanRWillamsDCharafU (ed), Advances in biofilm science and engineering. Cytergy Publishing, Bozeman, MT."},{"key":"e_1_3_3_54_2","first-page":"207","article-title":"Staphylococcal biofilms","volume":"322","author":"Otto M","year":"2008","unstructured":"OttoM. 2008. Staphylococcal biofilms. Curr. Top. Microbiol. Immunol. 322:207\u2013228.","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.8.4653-4667.2005"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2011.06.004"},{"key":"e_1_3_3_57_2","first-page":"31","volume-title":"Goodman & Gilman's the pharmacological basis of therapeutics","author":"Ross EM","year":"2001","unstructured":"RossEMKenakinT. 2001. Pharmacodynamics: mechanism of drug action and the relationship between drug concentration and effect, p 31\u201343. In HardmanJLimbirdLE (ed), Goodman & Gilman's the pharmacological basis of therapeutics. McGraw-Hill Medical Publishing Division, New York, NY."},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.3.841-851.2006"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02609-12"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.5.1915-1922.2004"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl261"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1086\/380564"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.12.5842-5845.2004"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2008.06.030"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001044"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.05186-11"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1508.081187"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200767160-00005"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2012.11.013"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01353-09"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00019-11"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00237-11"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2010.01.026"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/11.2.109"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.10.2375"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00766-12"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2007.05.023"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/44.6.835"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01858-13","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01858-13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T22:39:13Z","timestamp":1645483153000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01858-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["10.1128\/AAC.01858-13"],"URL":"https:\/\/doi.org\/10.1128\/aac.01858-13","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"2013-08-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-12-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-02-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}